Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-1331|25|3|527-534

ISSN： 1351-5101

Source： EUROPEAN JOURNAL OF NEUROLOGY, Vol.25, Iss.3, 2018-03, pp. : 527-534

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibody persistence 1 year after pandemic H1N1 2009 influenza vaccination and immunogenicity of subsequent seasonal influenza vaccine among adult organ transplant patients

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 27, Iss. 2, 2014-02 ,pp. : 197-203

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multiple sclerosis: individualized disease susceptibility and therapy response

By Pravica Vera   Markovic Milos   Cupic Maja   Savic Emina   Popadic Dusan   Drulovic Jelena   Mostarica-Stojkovic Marija  

Biomarkers in Medicine, Vol. 7, Iss. 1, 2013-02 ,pp. : 59-71

Future Medicine

Access to resources Recommend Favorite

Randomized trial investigating the safety and efficacy of influenza vaccination in patients with antineutrophil cytoplasmic antibody‐associated vasculitis

By  

NEPHROLOGY, Vol. 20, Iss. 5, 2015-05 ,pp. : 343-351

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dose response to interferon therapy in multiple sclerosis: an evaluation of the evidence

By Freedman S. Mitchell  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 547-557

Informa Healthcare

Access to resources Recommend Favorite

Considerations for pre‐transfusion immunohaematology testing in patients receiving the anti‐CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma

By  

INTERNAL MEDICINE JOURNAL, Vol. 48, Iss. 2, 2018-02 ,pp. : 210-220

John Wiley & Sons Inc

Access to resources Recommend Favorite